- Lobbying
- Lobbying by Hemispherx Biopharma, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Stephen Northrup | Health Policy Director, Senate HELP Cmte. Health Policy Adviser, Sen. Michael Enzi |
Oscar Ramirez | Special Asst. to the Secretary, Dept. of Labor Chief of Staff, Rep. Hilda Solis Leg. Director/Deputy CoS, Rep. Al Green Leg. Asst./Asst. LD/LD, Rep. Joe Baca |
Nora Connors | Leg. Assistant, Sen. Dianne Feinstein |
Anthony Podesta | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Executive Office of the President (EOP)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: FDA regulation of therapies for chronic fatigue syndrome..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate